California’s stem cell agency to choose between investment banker and cardiologist
Cross posted from Nature Medicine’s Spoonful of Medicine blog on behalf of Elie Dolgin. CIRM nominees: Jonathan Thomas (left) and Frank Litvack (right) Six months after a bungled attempt to find a new leader, the California Institute for Regenerative Medicine (CIRM) yesterday announced two candidates to succeed Bob Klein, the architect and founding chairman of the $3 billion state stem cell agency. And with the option of electing either a bond financier or a cardiologist, the CIRM board now faces a stark choice over who will lead the San Francisco-based institute as it enters into its next phase. Klein, a … Read more
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells